Loading
Latest filing published 12 Nov 2008 for SCOLR Pharma, Inc., €3,092.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Reich Jeffrey across 2 companies, led by SCOLR Pharma, Inc. and Neurologix Inc/de. In total, 6 filings cover trades dated from 16 May 2008 to 11 November 2008.
The open-market record is one-sided, with 6 purchases worth €31k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The median purchase comes to €4,851.
The latest filing, published on 12 November 2008, reports an open-market purchase of €3,092 in SCOLR Pharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations